Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Patient-Focused Drug Development At 10: Where Does It Go From Here?

20 Oct 2014

• By Derrick Gingery

Related Content

Disease-Of-The-Quarter Club: FDA Plans 20 Patient Network Meetings Over Five Years

18 Jun 2012

“Patient Voice” Report Puts Chronic Fatigue Symptoms, Treatments In Benefit/Risk Framework

07 Oct 2013

Narcolepsy Meeting Focuses On Symptoms, But Some Urge Attention To Underlying Cause

07 Oct 2013

Related Companies

InterMune, Inc.

Boehringer Ingelheim GmbH

Additional Topics

United States Regulation Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.